Authors/Disclosures
|
Thomas Wychowski, MD
(University of Rochester)
|
The institution of Dr. Wychowski has received research support from UCB. |
|
Erika S. Roers
(Supernus Pharmaceuticals, Inc.)
|
No disclosure on file |
|
John Scagnelli, MD
|
The institution of Dr. Scagnelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Scagnelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Scagnelli has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen IDEC. The institution of Dr. Scagnelli has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Scagnelli has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for NC Neurologic Society. |
|
|
No disclosure on file |
|
Robert G. Holloway, MD, MPH, FAAN
(University of Rochester Medical Center)
|
Dr. Holloway has nothing to disclose. |
|
|
No disclosure on file |